We have also shown that FOXA1 binding profiles are influenced by the SWI/SNF complex (42) and the histone methyltransferase KMT2D in breast cancer (43), suggesting a possible role for the chromatin landscape to evoke further differences in DNA binding for FOXA1. Here, PRDM9 is linked to breast cancer.